Aytu BioPharma (AYTU) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Aytu BioPharma (AYTU) is Moderate Underperform.

The composite score behind that read is -0.36, weighing +0.09 of bullish evidence against -0.45 bearish.

Aytu BioPharma last closed at $2.05, +0.49% on the session.

Against the IVW growth benchmark the position is -0.12% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

Aytu BioPharma has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Aytu BioPharma in the 18th percentile on return on equity, where 100 is best.

Aytu BioPharma is classified under Health Care / Pharmaceuticals, with a market capitalisation of $22.17M.

StockMap tracks Aytu BioPharma as the 114th largest of the 142 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 61 Moderate Underperform, 57 Neutral, 19 Strong Underperform and 5 Moderate Outperform.

On that composite Aytu BioPharma ranks 99th of 142 in the group, against a group median of -0.24.